Related Articles
Dihydromyricetin induces mouse hepatoma Hepal‑6 cell apoptosis via the transforming growth factor‑β pathway
Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells
Multiple molecular and cellular mechanisms of the antitumour effect of dihydromyricetin (Review)
Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway
Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway